1. Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain
- Author
-
Uta Mueller, Martin Schulz, and Nina Griese-Mammen
- Subjects
Pharmacology ,Medication review ,Medication therapy management ,Pharmaceutical Science ,Community pharmacy services ,Pharmacology (medical) ,1115 Pharmacology and Pharmaceutical Sciences, 1199 Other Medical and Health Sciences ,Pharmacology & Pharmacy ,Pharmacy ,Toxicology ,600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik ,Pharmaceutical services - Abstract
Over the last two decades, community pharmacy has experienced major changes as the role of pharmacists is evolving from a product to a service and a patient focus. As part of this change, new and innovative clinical pharmacy services aimed at improving medicines use and patient outcomes have been designed, both nationally and internationally. Since June 2022, five services are reimbursed by all statutory health insurance funds and private insurance companies in Germany: medication review for patients with polymedication; blood pressure control in hypertension; assuring proper inhalation techniques for patients receiving a new device or a device change; medication review including a follow-up for patients taking oral anticancer drugs or immunosuppressants post-transplantation. Beyond reimbursement, the upscaling and sustainable provision of these professional services are now the main challenges. Implementation research will provide important information for the further development of pharmaceutical care programs.
- Published
- 2023
- Full Text
- View/download PDF